Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.

A single invitation for a prostate-specific antigen (PSA) screening test results in a small but significant reduction in prostate cancer deaths, but also leads to overdiagnosis and missed early ...

This is a large-scale, population-based, observational study of two screening strategies: annual PSA screening and no screening. We used data from 537,599 US Medicare (2001-2008) beneficiaries age ...

SAN FRANCISCO—Offering PSA testing for free is associated with a reduction in prostate cancer mortality, according to an Austrian study. The study, presented at the American Urological Association ...

A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...

A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term follow-up results from the European Randomized Study of Screening for ...

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...

About The Study: A single invitation for prostate-specific antigen (PSA) screening compared with standard practice without routine screening reduced prostate cancer deaths at a median follow-up of 15 ...

Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate ...

Please provide your email address to receive an email when new articles are posted on . PSA screening appeared associated with lower prostate cancer-specific mortality among both black men and ...

Long-term results from a European study showed that prostate cancer mortality was 13% lower in the PSA screening group versus the control group. Compared with the trial update at 16 years, the number ...